Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.AuthorsMikhael, Joseph; Belhadj-Merzoug, Karim; Hulin, Cyrille; Vincent, Laure; Moreau, Philippe; Gasparetto, Cristina; Pour, Ludek; Spicka, Ivan; Vij, Ravi; Zonder, Jeffrey; Atanackovic, Djordje; Gabrail, Nashat; Martin, Thomas G.; Perrot, Aurore; Bensfia, Samira; Weng, Qilong; Brillac, Claire; Semiond, Dorothée; Macé, Sandrine; Corzo, Kathryn P.SubjectsMULTIPLE myeloma; DARATUMUMABPublicationBlood Cancer Journal, 2021, Vol 11, Issue 5, p1ISSN2044-5385Publication typeLetter to the EditorDOI10.1038/s41408-021-00478-4